Xu W, Zhou K, Wang T, Yang S, et al. Orelabrutinib in relapsed or refractory chronic lymphocytic leukemia/small lymphocytic lymphoma patients: Multi-center, single-arm, open-label, phase 2 study. Am J Hematol 2023 Jan 22. doi: 10.1002/ajh.26826.
PMID: 36683422